Anterios Inc.

Quick facts

Phase 2 pipeline

• ANT-1207 · Diabetes
  ANT-1207 is a small molecule inhibitor of the sodium-glucose cotransporter 2 (SGLT2).
• ANT-1401 · Diabetes
  ANT-1401 is a small molecule that targets the SGLT2 receptor.
• ANT-1403

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Anterios Inc. portfolio CI brief
• Anterios Inc. pipeline updates RSS